Nocturia Market Report and Forecast 2025-2034

The nocturia market size was valued at USD 3.30 Billion in 2024, driven by the rising prevalence of nocturia across the 8 major markets. The market is expected to grow at a CAGR of 8.30% during the forecast period of 2025-2034, with the values likely to rise USD 7.32 Billion by 2034.

Nocturia Market Overview

Nocturia is a medical condition characterized by excessive urination at night, with the affected individual visiting the bathroom twice or more at nighttime. Patients with nocturia can suffer from sleep deprivation which can greatly impact the quality of life. It is also linked with obesity, depression, diabetes, and heart disease, among others.

The market is driven by the rising prevalence of nocturia, with over 50% of men and women aged 60 or more reported to be diagnosed with the condition. The incidence of nocturia in older men is higher than in older women, amounting to 50% in men between 70 to 79 years having two or more nightly voids. The growing number of patients with nocturia is expected to directly drive the nocturia market demand, with more and more individuals seeking effective treatment options to manage the symptoms.

As people age, they are more likely to experience nocturia, which also tends to become more severe. With the rising geriatric population, clinically significant nocturia cases are expected to surge. According to the United Nations Population Fund, the number of older people aged 60 years, or more is expected to reach 2.1 billion worldwide, accounting for 22% of the total population. Moreover, it is estimated that the elderly population in India will double, almost reaching 347 million in 2050. This indicates that the rapid growth of the geriatric population is likely to augment nocturia market share in the coming years.

The market is also supported by increased research initiatives aimed at finding innovative treatment solutions to treat nocturia. In April 2023, a randomized controlled trial revealed the potential of Erbium YAG laser treatment to manage overactive bladder, often accompanied by frequent urination and nocturia. The study showed positive results, with women receiving the intervention reporting less nocturia and urination urgency, along with additional benefits. The development of such novel treatment methods is anticipated to boost nocturia market growth.

Other factors that impact the market dynamics include the growing technological advancements in diagnostic tools and digital health applications for monitoring symptoms and treatment efficacy. Rising healthcare expenditure, and the introduction of advanced therapies also impact the market significantly. Moreover, the market is expected to witness increased demand owing to the high prevalence rate of chronic conditions such as obesity and hypertension that make an individual prone to nocturia.

Nocturia Market Trends

Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:

Advancements in Treatment Options

Technological advancements coupled with pharmaceutical progressions have led to the development of new and improved treatment options for nocturia. From behavioral interventions to pharmacotherapy and surgical procedures, the rising accessibility of these therapeutic interventions is fuelling the nocturia market share. Further, the market is witnessing a diversification of available treatments, which attracts a wider patient base, thereby driving market demand.

Integration of Digital Health Technologies

The integration of digital health technologies, such as mobile apps for bladder monitoring and telehealth services for remote consultations, is significantly impacting the market landscape. With the help of these digital tools, patient management along with adherence to treatment plans are likely to improve. This market trend follows a patient-centric approach by leveraging digital solutions, focusing on the convenience of the patients, and is expected to bolster nocturia market demand in the coming years.

Heightened Awareness and Diagnosis

The rising awareness among the public and healthcare professionals about nocturia as a treatable condition, rather than a normal part of aging, has accelerated diagnosis rates and encouraged treatment-seeking behaviour. Moreover, this trend also supports ongoing research and development aimed at finding effective therapeutics to treat nocturia, contributing to market growth and innovation in the healthcare sector.

Rising Healthcare Expenditure

One of the significant nocturia market trends is the increased healthcare expenditure that enables substantial investment in the diagnosis and treatment of nocturia. This is expected to accelerate the development of advanced therapies more accessible to a broader patient population. This financial investment also supports the adoption of innovative medical technologies, further driving market growth.

Nocturia Market Segmentation

Nocturia Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Disease Type

• Polyuria
• Nocturnal Polyuria
• Low Nocturnal Bladder Capacity
• Mixed Nocturia

The market is segmented by disease type into polyuria, nocturnal polyuria, low nocturnal bladder capacity, and mixed nocturia. In about 88% of patients, the cause of nocturia is nocturnal polyuria which is characterized by greater production of urine during nighttime.

Market Breakup by Drug Type

• Anti-cholinergic
• Desmopressin
• Antibiotic
• Anti-spasmodic
• Others

In terms of drug type, the market comprises anti-cholinergic drugs, desmopressin, antibiotics, anti-spasmodic, and other medications targeting various aspects of nocturia management. This market segment reflects the range of medications usually prescribed for treating nocturia. For instance, desmopressin is an antidiuretic that is usually given to nocturia patients to reduce the amount of urine produced.

Market Breakup by Dosage Form

• Tablet
• Nasal Spray

The nocturia market share by dosage forms includes tablets and nasal sprays. This segment offers different administration options according to specific patient needs and convenience.

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Drug Store
• Retail Pharmacies
• Online Pharmacies

Distribution channels for nocturia drugs are hospital pharmacies, drug stores, retail pharmacies, and online pharmacies. This segment provides various facilities or healthcare settings for patients to access medications.

Market Breakup by Region

• United States
• United Kingdom
• Germany
• France
• Italy
• Spain
• Japan
• India

Based on the region, the nocturia market segmentation includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. United States holds a significant portion of the market which can be attributed to the high prevalence rate of the disease in the region. It is estimated that 50 million individuals are affected by the condition, which can severely impact the overall health and daytime functioning of the patient. The rising number of nocturia cases along with heightened patient awareness and diagnostic rates are expected to drive the market demand in the regional market.

Nocturia Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Urigen Pharmaceuticals
• Glenmark Pharmaceuticals
• AbbVie Inc
• Teva Pharmaceuticals
• Avadel Pharmaceuticals
• Astellas Pharma
• Dainippon Sumitomo Pharma
• Feering Pharmaceuticals
• AA Pharma Inc
• Pfizer Inc

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Queries Solved in the Nocturia Market Report

• How has the market performed so far and how will it perform in the coming years?
• What are the major market trends influencing the market?
• What are the market's major drivers, opportunities, and restraints?
• What will be the effect of each driver, challenge, and opportunity on the market?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How does the prevalence and incidence of nocturia affect the market landscape?
• How does the rise in the geriatric population impact the nocturia market size?
• What disease type will dominate the market share?
• Which dosage form is expected to have a high market value in the coming years?
• Which drug type will experience the highest demand in the market segment?
• Which distribution channel will significantly impact market growth?
• How will the ongoing clinical trials impact the market value during the forecast period?
• What are the factors driving regional disparities in nocturia treatment and outcomes?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.